[Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide].
D000368:Aged; D000941:Antigens / Q000032:analysis; D001381:Azepines / Q000627:therapeutic use*; D001645:Biguanides / Q000627:therapeutic use*; D001786:Blood Glucose / Q000032:analysis; D003864:Depression, Chemical; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007328:Insulin / Q000032:analysis / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010080:Oxazoles / Q000627:therapeutic use*; D013453:Sulfonylurea Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D000941:Antigens; D001381:Azepines; D001645:Biguanides; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D010080:Oxazoles; D013453:Sulfonylurea Compounds
Verhalten von Seruminsulin unter dem Einfluss von Glisoxepid mit oder ohne Butylbiguanid